Principal Financial Group Inc. lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 3.3% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 141,083 shares of the company's stock after selling 4,752 shares during the period. Principal Financial Group Inc. owned approximately 0.11% of Henry Schein worth $9,763,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Versant Capital Management Inc lifted its position in shares of Henry Schein by 274.6% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after buying an additional 335 shares during the last quarter. Quent Capital LLC lifted its holdings in shares of Henry Schein by 91.2% during the fourth quarter. Quent Capital LLC now owns 677 shares of the company's stock worth $47,000 after purchasing an additional 323 shares during the period. City State Bank bought a new stake in shares of Henry Schein in the fourth quarter worth $55,000. Farther Finance Advisors LLC increased its holdings in Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after purchasing an additional 346 shares during the period. Finally, Allworth Financial LP raised its position in Henry Schein by 180.7% during the 4th quarter. Allworth Financial LP now owns 946 shares of the company's stock worth $71,000 after purchasing an additional 609 shares during the last quarter. 96.62% of the stock is owned by institutional investors.
Henry Schein Stock Down 0.2 %
Shares of NASDAQ:HSIC traded down $0.11 during midday trading on Tuesday, hitting $70.70. 1,082,113 shares of the company's stock were exchanged, compared to its average volume of 1,468,035. Henry Schein, Inc. has a 12 month low of $63.67 and a 12 month high of $82.49. The company has a market cap of $8.78 billion, a PE ratio of 29.10, a price-to-earnings-growth ratio of 2.13 and a beta of 0.91. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The stock has a 50 day moving average price of $74.41 and a 200-day moving average price of $72.51.
Henry Schein (NASDAQ:HSIC - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to analysts' expectations of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $0.66 earnings per share. On average, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.
Analyst Ratings Changes
Several analysts recently commented on the company. Barrington Research reiterated an "outperform" rating and issued a $90.00 target price on shares of Henry Schein in a report on Wednesday, February 26th. Bank of America upgraded shares of Henry Schein from an "underperform" rating to a "buy" rating and increased their price objective for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. Mizuho initiated coverage on shares of Henry Schein in a research report on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target on the stock. Wells Fargo & Company initiated coverage on Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price objective for the company. Finally, StockNews.com upgraded Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Henry Schein has an average rating of "Moderate Buy" and an average target price of $81.10.
View Our Latest Research Report on HSIC
About Henry Schein
(
Free Report)
Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.
Featured Articles

Before you consider Henry Schein, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Henry Schein wasn't on the list.
While Henry Schein currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.